To further validate the in vivo relevance of these findings, we searched for ETF overexpression in single-cell RNA-seq data generated from 14-week-old βEedKO β cells (early in the progression toward dedifferentiation and diabetes). This evidence concerns the gene TEAD2 and diabetes mellitus.